Active Shortage

GLN-DAPAGLIFLOZIN

GLENMARK PHARMACEUTICALS CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of GLN-DAPAGLIFLOZIN in Canada?

Yes. GLN-DAPAGLIFLOZIN 10MG has an active shortage reported to Health Canada (last updated February 13, 2026).

Why is GLN-DAPAGLIFLOZIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will GLN-DAPAGLIFLOZIN be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products

Affected strength10MG

Last updated2026-02-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PMS-DAPAGLIFLOZIN

PHARMASCIENCE INC

10MG · DIN 02531569

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-DAPAGLIFLOZIN

AURO PHARMA INC

10MG · DIN 02531410

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PRO-DAPAGLIFLOZIN

PRO DOC LIMITEE

10MG · DIN 02537664

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

NAT-DAPAGLIFLOZIN

NATCO PHARMA (CANADA) INC

10MG · DIN 02535874

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

FORXIGA

ASTRAZENECA CANADA INC

5MG · DIN 02435462

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

TARO-DAPAGLIFLOZIN

TARO PHARMACEUTICALS INC

5MG · DIN 02520591

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02519860

Strength

10MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

DAPAGLIFLOZIN

Tier

Unrated

Last Updated

2026-02-13

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from GLENMARK PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

DIN 02466783

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

DIN 02462060

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21

DIN 02421437

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28

DIN 02421445

GLN-APREMILAST

30MG · DIN 02518910

GLN-ATOVAQUONE

750MG · DIN 02528495